Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Legend Biotech | 20-F: Registration statement / Annual report / Transition report
Legend Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Legend Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144/A: Others
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144
Legend Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GenScript Biotech Corporation(47.99%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hillhouse Investment Management, Ltd.(3.6%),HHLR Advisors, Ltd.(3.6%)
Legend Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(5.9%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.040%),Abigail P. Johnson(7.040%)
No Data